Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP816044.RAdQWkOFG8-eykdb4Giw2N5vj861ZbVK5xMJ990Xzatl8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP816044.RAdQWkOFG8-eykdb4Giw2N5vj861ZbVK5xMJ990Xzatl8130_assertion type Assertion NP816044.RAdQWkOFG8-eykdb4Giw2N5vj861ZbVK5xMJ990Xzatl8130_head.
- NP816044.RAdQWkOFG8-eykdb4Giw2N5vj861ZbVK5xMJ990Xzatl8130_assertion description "[Our results show that Her2/neu targeting using Ad-based vectors for prostate cancer is feasible and may serve as a basis for the development of gene therapy of human prostate cancer as well as other Her2/neu-expressing cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP816044.RAdQWkOFG8-eykdb4Giw2N5vj861ZbVK5xMJ990Xzatl8130_provenance.
- NP816044.RAdQWkOFG8-eykdb4Giw2N5vj861ZbVK5xMJ990Xzatl8130_assertion evidence source_evidence_literature NP816044.RAdQWkOFG8-eykdb4Giw2N5vj861ZbVK5xMJ990Xzatl8130_provenance.
- NP816044.RAdQWkOFG8-eykdb4Giw2N5vj861ZbVK5xMJ990Xzatl8130_assertion SIO_000772 21875358 NP816044.RAdQWkOFG8-eykdb4Giw2N5vj861ZbVK5xMJ990Xzatl8130_provenance.
- NP816044.RAdQWkOFG8-eykdb4Giw2N5vj861ZbVK5xMJ990Xzatl8130_assertion wasDerivedFrom befree-20150227 NP816044.RAdQWkOFG8-eykdb4Giw2N5vj861ZbVK5xMJ990Xzatl8130_provenance.
- NP816044.RAdQWkOFG8-eykdb4Giw2N5vj861ZbVK5xMJ990Xzatl8130_assertion wasGeneratedBy ECO_0000203 NP816044.RAdQWkOFG8-eykdb4Giw2N5vj861ZbVK5xMJ990Xzatl8130_provenance.